Bernier v. Allen

CourtDistrict Court, District of Columbia
DecidedJuly 20, 2020
DocketCivil Action No. 2016-0828
StatusPublished

This text of Bernier v. Allen (Bernier v. Allen) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bernier v. Allen, (D.D.C. 2020).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA _________________________________________ ) JEAN-GABRIEL BERNIER, ) ) Plaintiff, ) ) v. ) Case No. 16-cv-00828 (APM) ) JEFF ALLEN, ) ) Defendant. ) _________________________________________ )

MEMORANDUM OPINION AND ORDER

I.

Plaintiff Jean-Gabriel Bernier, a federal prisoner, is suing Defendant Jeff Allen, Chief

Physician for the Bureau of Prisons, for violating his Eighth Amendment rights. Plaintiff claims

that, in December 2015, Defendant unconstitutionally denied him Harvoni, an antiviral drug that

effectively cures Hepatitis C. The court previously granted Defendant’s motion to dismiss on the

ground that Plaintiff had not plausibly alleged facts that could overcome Defendant’s qualified

immunity defense. Plaintiff now requests that the court either (1) reconsider its ruling and vacate

its previous Order dismissing the action, or (2) amend its Order to clarify that the dismissal is

without prejudice, and grant Plaintiff leave to file a Second Amended Complaint. The court finds

that Plaintiff’s proposed Second Amended Complaint cures the defects in his earlier pleading by

alleging facts that plausibly establish a clear violation of Plaintiff’s Eighth Amendment rights.

Therefore, the court grants Plaintiff’s motion to amend its previous Order and accepts for filing

Plaintiff’s proposed Second Amended Complaint. II.

The court has detailed the factual and procedural history of this case at length in its previous

opinions. See Mem. Op., ECF No. 88 [hereinafter Bernier III], at 1–2; Bernier v. Trump (Bernier

II), 299 F. Supp. 3d 150, 152–54 (D.D.C. 2018); Bernier v. Trump (Bernier I), 242 F. Supp. 3d 31,

35–37 (D.D.C. 2017). Therefore, the court will only briefly summarize the information that is

relevant for purposes of Plaintiff’s instant motion.

Plaintiff is a prisoner in custody of the Federal Bureau of Prisons (“BOP”) who suffers

from Hepatitis C. Am. Compl., ECF No. 70 [hereinafter Am. Compl.], ¶¶ 5, 7. In December 2015,

Plaintiff requested that the BOP treat his condition with Harvoni, a direct-acting antiviral drug,

which had been approved by the Food and Drug Administration one year prior, in October 2014.

Id. ¶¶ 13, 18, 22. Harvoni is extremely effective, curing nearly 100 percent of patients with

characteristics similar to those of Plaintiff, but it is not cheap: a 12-week course of treatment costs

approximately $94,000. Id. ¶¶ 13–14. On December 31, 2015, Defendant rejected Plaintiff’s

application, reasoning that Plaintiff’s symptoms did not qualify him for immediate treatment under

the BOP’s existing prioritization protocol for administering antiviral treatment to inmates with

chronic Hepatitis C infections. Id. ¶¶ 19, 21.

Proceeding pro se, Plaintiff filed this action in May 2016. See generally Compl.,

ECF No. 1. Plaintiff alleged, among other things, that Defendant violated Plaintiff’s Eighth

Amendment rights when he denied Plaintiff’s request for Harvoni treatment in December 2015.

See id. ¶¶ 10–27a, 46. In 2017, the court granted Defendant’s motion to dismiss on the ground

that Plaintiff had not plausibly overcome Defendant’s qualified immunity defense. Bernier I, 242

F. Supp. 3d at 39. The court later reconsidered its decision, finding that it had framed the asserted

Eighth Amendment right too narrowly. See Bernier II, 299 F. Supp. 3d at 157. The court

2 nevertheless dismissed the action for insufficient service of process, but allowed Plaintiff to file

an amended complaint and to properly serve it on Defendant. See id. at 157–59. In June 2018,

Plaintiff filed an amended complaint—this time with the help of an attorney—and served

Defendant shortly thereafter. See generally Am. Compl.; Aff. of Service, ECF No. 72.

Once again, the court dismissed Plaintiff’s Amended Complaint on qualified immunity

grounds. The court rejected Plaintiff’s contention that the Eighth Amendment right in question

should be broadly defined as the “right of prisoners to adequate medical care, and to be free from

deliberate indifference to their serious medical needs.” See Bernier III at 4 (quoting Pl.’s Mem.

of P. & A. in Opp’n to Def.’s Mot. to Dismiss or for Summ. J., ECF No. 83, at 15). This “general

proposition,” the court reasoned, was not sufficiently “particularized . . . so that the contours of

the right are clear to a reasonable official.” Id. at 4–5 (quoting Reichle v. Howards, 566 U.S. 658,

665 (2012)).

Next, the court considered whether Plaintiff had plausibly alleged any of the three more

narrowly defined Eighth Amendment violations outlined in Abu-Jamal v. Kerestes, 779 F. App’x

893 (3d Cir. 2019). See id. at 5–6. In that case, the Third Circuit observed that a prison official

exhibits deliberate indifference in violation of the Eighth Amendment if he: (1) delays necessary

medical treatment for non-medical reasons, (2) opts for an easier and less efficacious treatment, or

(3) prevents an inmate from receiving recommended treatment for serious medical needs. See id.

(citing Abu-Jamal, 779 F. App’x at 900). Plaintiff did “not rely on either the first or second type

of violation” identified in Abu-Jamal, but instead “h[u]ng his hat” on only the third type of

violation. Id. at 6–7. In support of his claim that Defendant prevented him from receiving

recommended treatment for a serious medical need, Plaintiff noted that, in October 2015—two

months before Defendant rejected his request for Harvoni treatment—a panel of experts with the

3 American Association for the Study of Liver Disease (“AASLD”) and the Infectious Diseases

Society of America (“IDSA”) declared that “treatment with [direct-acting antiviral drugs] is

recommended for all patients with chronic [Hepatitis C].” See Am. Compl. ¶ 43. Plaintiff argued

that by denying Plaintiff’s treatment request on the basis of the BOP’s then-existing priority

treatment protocol, Defendant “disregarded the medical standard of care for treatment of [Hepatitis

C] infection . . . , in reliance upon a prioritization protocol no longer consistent with accepted

professional medical judgment.” Id. ¶ 45.

The court held that Plaintiff had not plausibly pleaded a clear Eighth Amendment violation

for three reasons. First, the AASLD/IDSA’s recommendation to treat all Hepatitis C patients with

direct-acting antiviral drugs was “qualified . . . in ways relevant to prison populations,” and was

not “unequivocal” as Plaintiff had argued. Bernier III at 7–8 (cleaned up). Second, the “timing of

the AASLD/IDSA panel’s recommendation and the rapidly changing medical landscape

undermine[d] the notion that Plaintiff had a settled, absolute right to treatment at the time of

[Defendant’s] decision.” Id. at 8. The court noted that AASLD/IDSA had a prioritization protocol

that was analogous to the BOP’s until “a mere two months” before Defendant denied Plaintiff’s

application in December 2015, and that BOP did not “sit still” following the AASLD/IDSA’s new

recommendation; rather, it updated its guidance in May 2016, and again in October 2016,

whereupon Plaintiff became eligible for treatment with Harvoni or an analogous drug. Id. at 8–9.

Finally, the court found that Defendant’s decision was not plainly incompetent or a knowing

violation of the law because it was based on Plaintiff’s low “APRI score,” a medically-accepted

diagnostic measure of liver cirrhosis. Id. at 10; see also id. at 7. Though Plaintiff also pointed to

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Mitchell v. Forsyth
472 U.S. 511 (Supreme Court, 1985)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Pearson v. Callahan
555 U.S. 223 (Supreme Court, 2009)
Hostetler v. Green
323 F. App'x 653 (Tenth Circuit, 2009)
Roe v. Elyea
631 F.3d 843 (Seventh Circuit, 2011)
Baker v. District of Columbia
326 F.3d 1302 (D.C. Circuit, 2003)
Ciralsky v. Central Intelligence Agency
355 F.3d 661 (D.C. Circuit, 2004)
Belizan, Monica v. Hershon, Simon
434 F.3d 579 (D.C. Circuit, 2006)
Brown v. District of Columbia
514 F.3d 1279 (D.C. Circuit, 2008)
Bingham v. Thomas
654 F.3d 1171 (Eleventh Circuit, 2011)
Keith Brown v. Jeffrey Beard
445 F. App'x 453 (Third Circuit, 2011)
Roger Rudder v. Shannon Williams
666 F.3d 790 (D.C. Circuit, 2012)
Thompson v. Williams
56 F.3d 1385 (Fifth Circuit, 1995)
Myrna O'Dell Firestone v. Leonard K. Firestone
76 F.3d 1205 (D.C. Circuit, 1996)
Reynolds v. Wagner
128 F.3d 166 (Third Circuit, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
Bernier v. Allen, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bernier-v-allen-dcd-2020.